WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 4 fonti

Gobierno firma acuerdo con empresa surcoreana para avanzar en producción de vacunas humanas

Vecol y SK bioscience anunciaron la firma de un acuerdo para avanzar en producción de vacunas humanas en Colombia.

Raccontata da

elespectador.com

koreatimes.co.kr

koreaherald.com

pharmaceutical-technology.com

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

elespectador.comStai leggendo1 mesi fa

Gobierno firma acuerdo con empresa surcoreana para avanzar en producción de vacunas humanas

Vecol y SK bioscience anunciaron la firma de un acuerdo para avanzar en producción de vacunas humanas en Colombia.

Timeline cronologica

lunedì 25 maggio 2026·elespectador.com
Gobierno firma acuerdo con empresa surcoreana para avanzar en producción de vacunas humanas
Vecol y SK bioscience anunciaron la firma de un acuerdo para avanzar en producción de vacunas humanas en Colombia.
martedì 26 maggio 2026·koreatimes.co.kr
SK Bioscience to license vaccine technology to Colombia - The Korea Times
SK Bioscience will license its vaccine technology to Colombia’s state-owned pharmaceutical firm VECOL and cooperate in establishing a local manufac...

pharmaceutical-technology.com

1 mesi fa

SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative

SK bioscience has signed a vaccine technology transfer and manufacturing deal with VECOL, becoming part of Colombia’s $260m vaccine localisation initiative.

Leggi questa versione → originale

koreatimes.co.kr1 mesi fa

SK Bioscience to license vaccine technology to Colombia - The Korea Times

SK Bioscience signed a technology licensing agreement with Colombia's VECOL, including 600,000 doses of SKYVaricella ordered for 2026, backed by a $260M national vaccine localization program over 10 years. The deal signals a growing market for WHO-prequalified vaccine manufacturers willing to commit to in-country tech transfer — a model increasingly required for public health procurement across emerging markets.

Leggi questa versione → originale

koreaherald.com1 mesi fa

SK Bioscience joins Colombia’s vaccine localization project

SK Bioscience said Tuesday it signed an agreement with VECOL, a state-run producer of animal health and biotechnology products in Colombia, for vaccine technolo

Leggi questa versione → originale

martedì 26 maggio 2026·

koreaherald.com

SK Bioscience joins Colombia’s vaccine localization project

SK Bioscience said Tuesday it signed an agreement with VECOL, a state-run producer of animal health and biotechnology products in Colombia, for vaccine technolo

mercoledì 27 maggio 2026·

pharmaceutical-technology.com

SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative

SK bioscience has signed a vaccine technology transfer and manufacturing deal with VECOL, becoming part of Colombia’s $260m vaccine localisation initiative.